Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals
Ansel Shao Pin Tang(National University of Singapore), Cheng Han Ng(Kurume University), Darren Jun Hao Tan(National University Hospital), Jingxuan Quek(National University of Singapore), Benjamin Yong‐Qiang Tan(National University of Singapore), Vijay K. Sharma(Cornell University), Wen Hui Lim(National University of Singapore), May Zin Myint(National University Hospital), Jieling Xiao(Guangzhou Center for Disease Control and Prevention), Keng Siang Lee(University of Bristol), Mark Muthiah(National University of Singapore), Snow Yunni Lin(National University of Singapore), Phoebe Wen Lin Tay(National University of Singapore), Arun J. Sanyal(Virginia Commonwealth University), Kai En Chan(National University of Singapore), Apichat Kaewdech(Prince of Songkla University), Nicholas Chew(National University Health System), Mohammad Shadab Siddiqui(Virginia Commonwealth University), Margaret Teng(National University of Singapore), Daniel Q. Huang(National University of Singapore)
Cited by 97
Related Papers
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
|Hepatology|2017|7.2k
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A longitudinal study on the mental health of general population during the COVID-19 epidemic in China
|Brain Behavior and Immunity|2020|2.7k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k